edward kim, md, on anti-pd-l1/pd-1 combination therapies in treatment of lung cancer
Published 7 years ago • 31 plays • Length 1:05
Download video MP4
Download video MP3
Similar videos
-
3:01
jack west, md, on anti-pd-l1/pd-1 therapy in combination with chemotherapy & targeted therapies
-
2:49
jack west, md, discusses pd-l1/pd-1 therapy in lung cancer treatment algorithms
-
1:27
edward kim, md, offers his opinion on the biggest news in lung cancer before and during asco 2017
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
0:47
edward kim, md, comments on gefitinib versus vinorelbine-cisplatin as adjuvant treatment in nsclc
-
2:21
dr. kim on clinical trial eligibility criteria in lung cancer
-
11:56
dr. edward s. kim on his “wish list" for the future of immunotherapy in nsclc
-
1:23
dr. edward kim on indicating patient populations with biomarkers in nsclc
-
0:58
dr. chandra belani on selecting the best anti pd-l1 agent in lung cancer
-
![anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]](https://i.ytimg.com/vi/9UUNnpNMpGE/mqdefault.jpg)
2:30
anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]
-
7:22
pd-1 inhibition in lung cancer
-
2:51
a discussion on immune checkpoint inhibitors in lung cancer
-
1:28
dr. kim on the importance of biomarker testing for lung cancer
-
4:10
combination of medi0680, an anti-pd-1 antibody, with durvalumab, an anti-pd-l1 antibody
-
3:34
pearls from: edward kim, md - medpage today
-
2:03
dr. natale on the utility of pd-l1 and tmb in lung cancer
-
18:58
pd-l1 testing by immunohistochemistry
-
1:11
pd-1 checkpoint inhibition impacts treatment of melanoma and lung cancer
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
Clip.africa.com - Privacy-policy